Balyasny Asset Management’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-51,880
| Closed | -$787K | – | 1675 |
|
|
2019
Q4 | $787K | Sell |
51,880
-261,605
| -83% | -$2.26M | ﹤0.01% | 924 |
|
|
2019
Q3 | $2M | Buy |
313,485
+258,808
| +473% | +$2.16M | 0.01% | 707 |
|
|
2019
Q2 | $523K | Sell |
54,677
-135,142
| -71% | -$1.46M | ﹤0.01% | 1219 |
|
|
2019
Q1 | $2.57M | Buy |
+189,819
| New | +$1.58M | 0.02% | 751 |
|
|
2018
Q3 | – | Sell |
-12,310
| Closed | -$113K | – | 2215 |
|
|
2018
Q2 | $113K | Sell |
12,310
-110,915
| -90% | -$1.03M | ﹤0.01% | 1701 |
|
|
2018
Q1 | $985K | Sell |
123,225
-840,189
| -87% | -$18.3M | ﹤0.01% | 1210 |
|
|
2017
Q4 | $26.8M | Buy |
963,414
+526,371
| +120% | +$14M | 0.08% | 322 |
|
|
2017
Q3 | $11.8M | Buy |
437,043
+85,562
| +24% | +$2.24M | 0.05% | 449 |
|
|
2017
Q2 | $10.2M | Sell |
351,481
-424,705
| -55% | -$12.9M | 0.04% | 533 |
|
|
2017
Q1 | $26.5M | Buy |
776,186
+157,211
| +25% | +$5.07M | 0.12% | 217 |
|
|
2016
Q4 | $18.8M | Sell |
618,975
-130,026
| -17% | -$4.19M | 0.1% | 287 |
|
|
2016
Q3 | $25.3M | Buy |
749,001
+136,970
| +22% | +$4.41M | 0.15% | 205 |
|
|
2016
Q2 | $17.9M | Buy |
612,031
+346,950
| +131% | +$9.57M | 0.12% | 237 |
|
|
2016
Q1 | $5.48M | Buy |
265,081
+62,610
| +31% | +$1.54M | 0.03% | 520 |
|
|
2015
Q4 | $7.01M | Buy |
202,471
+20,971
| +12% | +$602K | 0.05% | 434 |
|
|
2015
Q3 | $4.24M | Buy |
+181,500
| New | +$4.41M | 0.03% | 551 |
|
Balyasny Asset Management's DERM Position: Q1 2020 in Review
Balyasny Asset Management sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 51,880 shares — an estimated $787K sold.
Balyasny Asset Management first reported a position in DERM in Q3 2015 and held it in 16 quarters. The position peaked at $26.8M in Q4 2017. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Balyasny Asset Management reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Balyasny Asset Management sold 51,880 Dermira, Inc. shares in Q1 2020, an estimated $787K.
- Balyasny Asset Management first reported a position in Dermira, Inc. in Q3 2015 and held it in 16 quarters.
- Balyasny Asset Management's Dermira, Inc. position peaked at $26.8M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Balyasny Asset Management's 13F filing for Q1 2020, filed 15 May 2020.